Increased membrane shedding - indicated by an elevation of CD133-enriched membrane particles - into the CSF in partial epilepsy

Epilepsy Research

Volumn 99, Issue 1-2, 2012, Pages 101-106

  Huttner, Hagen B ^a,b   Corbeil, Denis ^b   Thirmeyer, Christina ^a   Coras, Roland ^a   Köhrmann, Martin ^a   Mauer, Christoph ^a   Kuramatsu, Joji B ^a   Kloska, Stephan P ^a   Doerfler, Arnd ^a   Weigel, Daniel ^a   Klucken, Jochen ^a   Winkler, Jürgen ^a   Pauli, Elisabeth ^a   Schwab, Stefan ^a   Hamer, Hajo M ^a   Kasper, Burkhard S ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

Author keywords

CD133; CSF; Epilepsy; Membrane shedding

Indexed keywords

CD133 ANTIGEN;

ADULT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BRAIN TUMOR; CENTRIFUGATION; CEREBROSPINAL FLUID; CHEMOLUMINESCENCE; CLINICAL ARTICLE; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; DYSPLASIA; FEMALE; FOCAL EPILEPSY; HIPPOCAMPAL SCLEROSIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MALE; MEMBRANE BIOLOGY; MEMBRANE PARTICLE; MEMBRANE SHEDDING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIMPLE PARTIAL SEIZURE; TEMPORAL LOBE EPILEPSY; TONIC CLONIC SEIZURE;

ADULT; ANTIGENS, CD; BIOLOGICAL MARKERS; CACO-2 CELLS; CASE-CONTROL STUDIES; CELL-DERIVED MICROPARTICLES; EPILEPSIES, PARTIAL; FEMALE; GLYCOPROTEINS; HUMANS; MALE; MIDDLE AGED; PEPTIDES;

EID: 84857913304     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2011.10.029     Document Type: Article

References (53)

1. Balu D.T., Lucki I. Adult hippocampal neurogenesis: regulation, functional implications, and contribution to disease pathology. Neurosci. Biobehav. Rev. 2009, 33(3):232-252.
2. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., Dewhirst M.W., Bigner D.D., Rich J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760.
3. Blumenfeld H. From molecules to networks: cortical/subcortical interactions in the pathophysiology of idiopathic generalized epilepsy. Epilepsia 2003, 44(Suppl. 2):7-15.
4. Carlen M., Meletis K., Goritz C., Darsalia V., Evergren E., Tanigaki K., Amendola M., Barnabe-Heider F., Yeung M.S., Naldini L., Honjo T., Kokaia Z., Shupliakov O., Cassidy R.M., Lindvall O., Frisen J. Forebrain ependymal cells are Notch-dependent and generate neuroblasts and astrocytes after stroke. Nat. Neurosci. 2009, 12(3):259-267.
5. Corbeil D., Fargeas C.A., Huttner W.B. Rat prominin, like its mouse and human orthologues, is a pentaspan membrane glycoprotein. Biochem. Biophys. Res. Commun. 2001, 285(4):939-944.
6. Corbeil D., Joester A., Fargeas C.A., Jaszai J., Garwood J., Hellwig A., Werner H.B., Huttner W.B. Expression of distinct splice variants of the stem cell marker prominin-1 (CD133) in glial cells. Glia 2009, 57(8):860-874.
7. Corbeil D., Marzesco A.M., Wilsch-Brauninger M., Huttner W.B. The intriguing links between prominin-1 (CD133), cholesterol-based membrane microdomains, remodeling of apical plasma membrane protrusions, extracellular membrane particles, and (neuro)epithelial cell differentiation. FEBS Lett. 2010, 584(9):1659-1664.
8. Corbeil D., Roper K., Hellwig A., Tavian M., Miraglia S., Watt S.M., Simmons P.J., Peault B., Buck D.W., Huttner W.B. The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J. Biol. Chem. 2000, 275(8):5512-5520.
9. Coskun V., Wu H., Blanchi B., Tsao S., Kim K., Zhao J., Biancotti J.C., Hutnick L., Krueger R.C., Fan G., de Vellis J., Sun Y.E. CD133+ neural stem cells in the ependyma of mammalian postnatal forebrain. Proc. Natl. Acad. Sci. U.S.A. 2008, 105(3):1026-1031.
10. Danzer S.C. Postnatal and adult neurogenesis in the development of human disease. Neuroscientist 2008, 14(5):446-458.
11. Davidsson P., Jahn R., Bergquist J., Ekman R., Blennow K. Synaptotagmin, a synaptic vesicle protein, is present in human cerebrospinal fluid: a new biochemical marker for synaptic pathology in Alzheimer disease?. Mol. Chem. Neuropathol. 1996, 27(2):195-210.
12. Di Bonaventura C., Mari F., Vanacore N., Fattouch J., Zarabla A., Berardelli A., Manfredi M., Prencipe M., Giallonardo A.T. Status epilepticus in epileptic patients. Related syndromes, precipitating factors, treatment and outcome in a video-EEG population-based study. Seizure 2008, 17(6):535-548.
13. Doetsch F., Caille I., Lim D.A., Garcia-Verdugo J.M., Alvarez-Buylla A. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 1999, 97(6):703-716.
14. Dubreuil V., Marzesco A.M., Corbeil D., Huttner W.B., Wilsch-Brauninger M. Midbody and primary cilium of neural progenitors release extracellular membrane particles enriched in the stem cell marker prominin-1. J. Cell Biol. 2007, 176:483-495.
15. Duncan J.S. Imaging and epilepsy. Brain 1997, 120(Pt 2):339-377.
16. Eisch A.J., Cameron H.A., Encinas J.M., Meltzer L.A., Ming G.L., Overstreet-Wadiche L.S. Adult neurogenesis, mental health, and mental illness: hope or hype?. J. Neurosci. 2008, 28(46):11785-11791.
17. Fargeas C.A., Fonseca A.V., Huttner W.B., Corbeil D. Prominin-1 (CD133): from progenitor cells to human diseases. Future Lipidol. 2006, 1(2):213-225.
18. Fevrier B., Raposo G. Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr. Opin. Cell Biol. 2004, 16(4):415-421.
19. Florek M., Bauer N., Janich P., Wilsch-Braeuninger M., Fargeas C.A., Marzesco A.M., Ehninger G., Thiele C., Huttner W.B., Corbeil D. Prominin-2 is a cholesterol-binding protein associated with apical and basolateral plasmalemmal protrusions in polarized epithelial cells and released into urine. Cell Tissue Res. 2007, 328:31-47.
20. Florek M., Haase M., Marzesco A.M., Freund D., Ehninger G., Huttner W.B., Corbeil D. Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer. Cell Tissue Res. 2005, 319(1):15-26.
21. Glass M., Dragunow M. Neurochemical and morphological changes associated with human epilepsy. Brain Res. Brain Res. Rev. 1995, 21(1):29-41.
22. Hermann A., Maisel M., Liebau S., Gerlach M., Kleger A., Schwarz J., Kim K.S., Antoniadis G., Lerche H., Storch A. Mesodermal cell types induce neurogenesis from adult human hippocampal progenitor cells. J. Neurochem. 2006, 98(2):629-640.
23. Huhmer A.F., Biringer R.G., Amato H., Fonteh A.N., Harrington M.G. Protein analysis in human cerebrospinal fluid: physiological aspects, current progress and future challenges. Dis. Markers 2006, 22(1-2):3-26.
24. Huttner H.B., Janich P., Kohrmann M., Jaszai J., Siebzehnrubl F., Blumcke I., Suttorp M., Gahr M., Kuhnt D., Nimsky C., Krex D., Schackert G., Lowenbruck K., Reichmann H., Juttler E., Hacke W., Schellinger P.D., Schwab S., Wilsch-Brauninger M., Marzesco A.M., Corbeil D. The stem cell marker prominin-1/CD133 on membrane particles in human cerebrospinal fluid offers novel approaches for studying central nervous system disease. Stem Cells 2008, 26(3):698-705.
25. Jan M.M., Girvin J.P. Seizure semiology: value in identifying seizure origin. Can. J. Neurol. Sci. 2008, 35(1):22-30.
26. Jung K.H., Chu K., Lee S.T., Kim J.H., Kang K.M., Song E.C., Kim S.J., Park H.K., Kim M., Lee S.K., Roh J.K. Region-specific plasticity in the epileptic rat brain: a hippocampal and extrahippocampal analysis. Epilepsia 2009, 50(3):537-549.
27. Karbanova J., Missol-Kolka E., Fonseca A.V., Lorra C., Janich P., Hollerova H., Jaszai J., Ehrmann J., Kolar Z., Liebers C., Arl S., Subrtova D., Freund D., Mokry J., Huttner W.B., Corbeil D. The stem cell marker CD133 (Prominin-1) is expressed in various human glandular epithelia. J. Histochem. Cytochem. 2008, 56(11):977-993.
28. Kriegstein A., Alvarez-Buylla A. The glial nature of embryonic and adult neural stem cells. Annu. Rev. Neurosci. 2009, 32:149-184.
29. Kuruba R., Hattiangady B., Shetty A.K. Hippocampal neurogenesis and neural stem cells in temporal lobe epilepsy. Epilepsy Behav. 2009, 14(Suppl. 1):65-73.
30. Lerner J.T., Salamon N., Hauptman J.S., Velasco T.R., Hemb M., Wu J.Y., Sankar R., Donald Shields W., Engel J., Fried I., Cepeda C., Andre V.M., Levine M.S., Miyata H., Yong W.H., Vinters H.V., Mathern G.W. Assessment and surgical outcomes for mild type I and severe type II cortical dysplasia: a critical review and the UCLA experience. Epilepsia 2009, 50(6):1310-1335.
31. Marzesco A.M., Janich P., Wilsch-Brauninger M., Dubreuil V., Langenfeld K., Corbeil D., Huttner W.B. Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells. J. Cell Sci. 2005, 118(Pt 13):2849-2858.
32. Mathern G.W., Leiphart J.L., De Vera A., Adelson P.D., Seki T., Neder L., Leite J.P. Seizures decrease postnatal neurogenesis and granule cell development in the human fascia dentata. Epilepsia 2002, 43(Suppl. 5):68-73.
33. Parent J.M. Adult neurogenesis in the intact and epileptic dentate gyrus. Prog. Brain Res. 2007, 163:529-540.
34. Parent J.M., Elliott R.C., Pleasure S.J., Barbaro N.M., Lowenstein D.H. Aberrant seizure-induced neurogenesis in experimental temporal lobe epilepsy. Ann. Neurol. 2006, 59(1):81-91.
35. Parent J.M., von dem Bussche N., Lowenstein D.H. Prolonged seizures recruit caudal subventricular zone glial progenitors into the injured hippocampus. Hippocampus 2006, 16(3):321-328.
36. Pfenninger C.V., Roschupkina T., Hertwig F., Kottwitz D., Englund E., Bengzon J., Jacobsen S.E., Nuber U.A. CD133 is not present on neurogenic astrocytes in the adult subventricular zone, but on embryonic neural stem cells, ependymal cells, and glioblastoma cells. Cancer Res. 2007, 67(12):5727-5736.
37. Regesta G., Tanganelli P. Clinical aspects and biological bases of drug-resistant epilepsies. Epilepsy Res. 1999, 34(2-3):109-122.
38. Richardson G.D., Robson C.N., Lang S.H., Neal D.E., Maitland N.J., Collins A.T. CD133, a novel marker for human prostatic epithelial stem cells. J. Cell Sci. 2004, 117(Pt 16):3539-3545.
39. Robel S., Berninger B., Gotz M. The stem cell potential of glia: lessons from reactive gliosis. Nat. Rev. Neurosci. 2011, 12(2):88-104.
40. Roper S.N. Surgical treatment of the extratemporal epilepsies. Epilepsia 2009, 50(Suppl. 8):69-74.
41. Scharfman H.E., McCloskey D.P. Postnatal neurogenesis as a therapeutic target in temporal lobe epilepsy. Epilepsy Res. 2009, 85(2-3):150-161.
42. Simpson R.J., Jensen S.S., Lim J.W. Proteomic profiling of exosomes: current perspectives. Proteomics 2008, 8(19):4083-4099.
43. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003, 63(18):5821-5828.
44. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., Dirks P.B. Identification of human brain tumour initiating cells. Nature 2004, 432(7015):396-401.
45. Snead O.C. Basic mechanisms of generalized absence seizures. Ann. Neurol. 1995, 37(2):146-157.
46. Thom M., Eriksson S., Martinian L., Caboclo L.O., McEvoy A.W., Duncan J.S., Sisodiya S.M. Temporal lobe sclerosis associated with hippocampal sclerosis in temporal lobe epilepsy: neuropathological features. J. Neuropathol. Exp. Neurol. 2009, 68(8):928-938.
47. Thompson E.J. Proteins of the Cerebrospinal Fluid: Analysis and Interpretation in the Diagnosis and Treatment of Neurological Disease 2005, Elsevier.
48. van Breemen M.S., Wilms E.B., Vecht C.J. Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol. 2007, 6(5):421-430.
49. Van Paesschen W., Revesz T., Duncan J.S., King M.D., Connelly A. Quantitative neuropathology and quantitative magnetic resonance imaging of the hippocampus in temporal lobe epilepsy. Ann. Neurol. 1997, 42(5):756-766.
50. Wang L., Han Y., Chen D., Xiao Z., Xi Z., Xiao F., Wang X. Cerebrospinal fluid apolipoprotein E concentration decreases after seizure. Seizure 2010, 19(2):79-83.
51. Weigmann A., Corbeil D., Hellwig A., Huttner W.B. Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 1997, 94(23):12425-12430.
52. Ying Z., Gonzalez-Martinez J., Tilelli C., Bingaman W., Najm I. Expression of neural stem cell surface marker CD133 in balloon cells of human focal cortical dysplasia. Epilepsia 2005, 46(11):1716-1723.
53. Yuan X., Desiderio D.M. Proteomics analysis of human cerebrospinal fluid. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2005, 815(1-2):179-189.